CIK 0000318306
- Non-accelerated filer
- Smaller reporting company
ABEONA THERAPEUTICS INC.
Sign in to watch- Ticker
- ABEO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 830221517
- Phone
- +1 646-813-4701
- Business address
- 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
- 4 Shares withheld for taxes SVP, General Counsel gave up 563 shares (to pay taxes)
- 4 Open-market sale Director sold 327 shares at $3.90 ($1,275)
- 4 Open-market buy Chief Financial Officer bought 3,000 shares at an average $3.82 ($11,458)
- 4 Open-market buy SVP, General Counsel bought 3,000 shares at $3.80 ($11,400)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,187 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 338 shares at $4.45 ($1,504)
- 4 Grant or award Director acquired 58,689 shares (grant or award)
- 4 Grant or award Director acquired 58,689 shares (grant or award)
- 4 Grant or award Director acquired 58,689 shares (grant or award)
- 4 Grant or award Director acquired 58,689 shares (grant or award)
- 4 Grant or award Director acquired 58,689 shares (grant or award)
- 4 Grant or award Director acquired 58,689 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 336,826 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 141,908 shares (grant or award)
- 4 Grant or award SVP, General Counsel acquired 90,902 shares (grant or award)
- 4 Shares withheld for taxes Chief Executive Officer gave up 827 shares (to pay taxes)
- 4 Open-market sale Director sold 887 shares at $3.25 ($2,883)
- 4 Shares withheld for taxes SVP, General Counsel gave up 104 shares (to pay taxes)
- 4 Open-market sale Director sold 268 shares at $2.33 ($624)
Page 8 of 20 · 394 filings